Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay

Gynecologic Oncology

Volumn 128, Issue 2, 2013, Pages 252-259

  Bristow, Robert E ^a   Smith, Alan ^b   Zhang, Zhen ^c   Chan, Daniel W ^c   Crutcher, Gillian ^d   Fung, Eric T ^d   Munroe, Donald G ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Applied Clinical Intelligence   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d CIPHERGEN BIOSYSTEMS INC   (United States)

^e Vermillion Inc   (United States)

Author keywords

Ovarian malignancy; Risk stratification

Indexed keywords

CA 125 ANTIGEN;

ADNEXA DISEASE; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER RISK; CANCER SURGERY; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; GYNECOLOGIC SURGERY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE INDEX ASSAY; OVARY CANCER; PELVIS CANCER; PHYSICIAN; POSTMENOPAUSE; PREDICTION; PREDICTIVE VALUE; PREMENOPAUSE; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADNEXAL DISEASES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OVARIAN NEOPLASMS; YOUNG ADULT;

EID: 84872864406     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.11.022     Document Type: Article

References (30)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics 2012 CA Cancer J Clin 62 2012 10 29
2. M.E. Carney, J.M. Lancaster, C. Ford, A. Tsodikov, and C.L. Wiggins A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecol Oncol 84 2002 36 42 (Pubitemid 34056463)
3. S. Tingulstad, F.E. Skjeldestad, and B. Hagen The effect of centralization of primary surgery on survival in ovarian cancer patients Obstet Gynecol 102 2003 499 505 (Pubitemid 37311211)
4. S.M. Eisenkop, N.M. Spirtos, T.W. Montag, R.H. Nalick, and H.J. Wang The impact of subspecialty training on the management of advanced ovarian cancer Gynecol Oncol 47 1992 203 209 (Pubitemid 23001329)
5. M.J.A. Engelen, H.E. Kos, P.H.B. Willemse, J.G. Aalders, E.G.E. de Vries, and M. Schaapveld Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma Cancer 106 2006 589 598 (Pubitemid 43157622)
6. F. Vernooj, P. Heintz, E. Witteveen, and Y. van der Graaf The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review Gynecol Oncol 105 2007 801 812 (Pubitemid 46734206)
7. A. Olaitan, J. Weeks, A. Mocroft, J. Smith, K. Howe, and J. Murdoch The surgical management of women with ovarian cancer in the south west of England Br J Cancer 85 2001 1824 1830 (Pubitemid 34775316)
8. L. Elit, S.J. Bondy, L. Paszat, R. Przybysz, and M. Levine Outcomes in surgery for ovarian cancer Gynecol Oncol 87 2002 260 267 (Pubitemid 36034645)
9. F. Vernooj, A.P.M. Heintz, P.O. Witteveen, M. van der Heiden-van der Loo, J.W. Coebergh, and Y. van der Graaf Specialized care and survival of ovarian cancer patients in the Netherlands: nationwide cohort study J Natl Cancer Inst 100 2008 399 406 (Pubitemid 351480512)
10. C.C. Earle, D. Schrag, B.A. Neville, R. Yabroff, M. Topor, and A. Fahey Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients J Natl Cancer Inst 98 2006 173 180
11. L.R. Boyd, A.P. Novetsky, and J.P. Curtin Ovarian cancer care for the underserved: are surgical patterns of care different in a public hospital setting? Cancer 117 2011 777 783
12. J.E. Dodge, A.L. Covens, C. Lacchetti, L.M. Elit, T. Le, and M. Devries-Aboud Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis Gynecol Oncol 126 2012 157 166
13. The role of the generalist obstetrician gynecologist in the early detection of ovarian cancer. ACOG Committee Opinion Number 280. American College of Obstetricians and Gynecologists Obstet Gynecol 100 2002 1413 1416
14. The role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer. ACOG Committee Opinion Number 477. American College of Obstetricians and Gynecologists Obstet Gynecol 117 2011 742 746
15. F.R. Ueland, C.P. DeSimone, L.G. Seamon, R.A. Miller, S. Goodrich, and I. Podzielinski Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors Obstet Gynecol 117 2011 1289 1297
16. A.C. Dearking, G.D. Aletti, M.E. McGree, A.L. Weaver, M.K. Sommerfield, and W.A. Cliby How relevant are ACOG and SGO guidelines for referral of adnexal mass? Obstet Gynecol 110 2007 841 848 (Pubitemid 47508749)
17. W. Hoskins, L. Rice, and S. Rubin Ovarian cancer surgical practice guidelines Oncology 11 1997 896 904 (Pubitemid 127637971)
18. M. Grossi, M.A. Quinn, V.J. Thursfield, P.A. Francis, R.M. Rome, and R.S. Planner Ovarian cancer: patterns of care in Victoria during 1993-1995 Med J Aust 177 2002 11 21
19. R.D. Cress, K. Bauer, and C.D. O'Malley CR ovarian patterns of care study Gynecol Oncol 121 2011 94 99
20. B.A. Goff, B.J. Matthews, M. Wynn, H.G. Muntz, D.M. Lishner, and L.M. Baldwin Ovarian cancer: patterns of surgical care across the United States Gynecol Oncol 103 2006 383 390 (Pubitemid 44602199)
21. K.C. Giede, K. Kieser, J. Dodge, and B. Rosen Who should operate on patients with ovarian cancer? An evidence-based review Gynecol Oncol 99 2005 447 461 (Pubitemid 41502860)
22. K.H. Kim, G.N. Zsebik, J.M. Straughn, and C.N. Landen Management of complex pelvic masses using a multivariate index assay: a decision analysis Gynecol Oncol 2012 10.1016/j.ygyno.2012.05.027
23. P.M. Geomini, R.F. Kruitwagen, G.L. Bremer, L. Massuger, and B.W. Mol Should we centralize care for the patient suspected of having an ovarian malignancy? Gynecol Oncol 122 2011 95 99
24. S.L. Stewart, S.H. Rim, and T.B. Ricjards Gynecologic oncologists and ovarian cancer treatment: avenues for improved survival J Womens Health 20 2011 1257 1260
25. S.S. Im, A.N. Gordon, B.M. Buttin, C.A. Leath, B.S. Gostout, and C. Shah Validation of referral guidelines for women with pelvic masses Obstet Gynecol 105 2005 35 41 (Pubitemid 40189908)
26. P. Geomini, R. Kruitwagen, G.L. Bremer, J. Cnossen, and B.W.J. Mol The accuracy of risk scores in predicting ovarian malignancy Obstet Gynecol 113 2009 384 394
27. R.C. Bast Jr., F.J. Xu, Y.H. Yu, S. Barnhill, Z. Zhang, and G.B. Mills CA-125: the past and the future Int J Biol Markers 13 1998 179 187
28. R.G. Moore, C. Miller, P. Disilvestro, L.M. Landrum, W. Gajewski, and J.J. Ball Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass Obstet Gynecol 118 2011 280 288
29. M. Montagnana, E. Danese, O. Ruzzenente, V. Bresciani, T. Nuzzo, and M. Gelati The ROMA (risk of ovarian malignancy algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic masses: is it really useful? Clin Chem Lab Med 49 2011 521 525
30. T. Van Gorp, I. Cadron, E. Despierre, A. Daemen, K. Leunen, and F. Amant HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the risk of malignancy algorithm Br J Cancer 104 2011 863 870